期刊列表 » 期刊详情

1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（主办单位杂志社进入）：

https://journals.muhn.edu.cn/jad/home

https://journals.lww.com/joad/pages/default.aspx

4、投稿系统：https://review.jow.medknow.com/jad

5、主办单位杂志社官网：

https://journals.muhn.edu.cn/qks

6、官网邮箱：

editor@jadweb.org；jadweb@yahoo.com

7、官网电话：0898-66890465

8、期刊刊期：以Continuous publication形式出刊，一年出版1卷。

2025年6月11日星期三

《急性病杂志（英文）》作者须知

（Journal of Acute Disease）

【官网信息】

Information For Authors

The Editorial Process

A

manuscript will be reviewed for possible publication with the

understanding that it is being submitted to Journal of Acute Disease

alone at that point in time and has not been published anywhere,

simultaneously submitted, or already accepted for publication elsewhere.

The journal expects that authors would authorize one of them to

correspond with the Journal for all matters related to the manuscript.

All manuscripts received are duly acknowledged. On submission, editors

review all submitted manuscripts initially for suitability for formal

review. Manuscripts with insufficient originality, serious scientific or

technical flaws, or lack of a significant message are rejected before

proceeding for formal peer-review. Manuscripts that are unlikely to be

of interest to the Journal of Acute Disease readers are also liable to

be rejected at this stage itself.

Manuscripts

received from Editorial Board members will be screened by the Editor in

Chief and sent to external peer reviewers. The editorial board members

who are authors will be excluded from publication decisions.

Manuscripts

that are found suitable for publication in Journal of Acute Disease are

sent to two or more expert reviewers. During submission, the

contributor is requested to provide names of two or three qualified

reviewers who have had experience in the subject of the submitted

manuscript, but this is not mandatory. The reviewers should not be

affiliated with the same institutes as the contributor/s. However, the

selection of these reviewers is at the sole discretion of the editor.

The journal follows a double-blind review process, wherein the reviewers

and authors are unaware of each other's identity. Every manuscript is

also assigned to a member of the editorial team, who based on the

comments from the reviewers takes a final decision on the manuscript.

The comments and suggestions (acceptance/ rejection/ amendments in

manuscript) received from reviewers are conveyed to the corresponding

author. If required, the author is requested to provide a point by point

response to reviewers' comments and submit a revised version of the

manuscript. This process is repeated till reviewers and editors are

satisfied with the manuscript.

Manuscripts

accepted for publication are copy edited for grammar, punctuation,

print style, and format. Page proofs are sent to the corresponding

author. The corresponding author is expected to return the corrected

proofs within three days. It may not be possible to incorporate

corrections received after that period. The whole process of submission

of the manuscript to final decision and sending and receiving proofs is

completed online. To achieve faster and greater dissemination of

knowledge and information, the journal publishes articles online as

'Ahead of Print' immediately on acceptance.

Processes for appeals

The

authors do have the right to appeal if they have a genuine cause to

believe that the editorial board has wrongly rejected the paper. If the

authors wish to appeal the decision, they should email the editorial

office (email: editor@jadweb.org) explaining in detail the reason for

the appeal. The appeals will be acknowledged by the editorial office and

will be investigated in an unbiased manner. The processing of appeals

will be done within 6 – 8 weeks. While under appeal, the said manuscript

should not be submitted to other journals. The final decision rests

with the Editor in Chief of the journal. Second appeals are not

considered.

Anti-Plagiarism

Plagiarism

includes duplicate publication of the author's own work, in whole or in

part without proper citation or mispresenting other's ideas, words, and

other creative expression as one's own. The Journal follows strict

anti-plagiarism policy. All manuscripts submitted to Journal of Acute

Disease undergoes plagiarism check with commercially available software.

Based on the extent of plagiarism, authors may be asked to address any

minor duplication, or similarity with the previous published work. If

plagiarism is detected after publication, the Journal will investigate.

If plagiarism is established, the journal will notify the authors'

institution and funding bodies and will retract the plagiarised article.

To report plagiarism, contact the journal office (email:

editor@jadweb.org).

Clinical trial registry  

Journal

of Acute Disease would publish clinical trials that have been

registered with a clinical trial registry that allows free online access

to public. Registration in the following trial registers is acceptable:

https://ctri.nic.in/Clinicaltrials/login.php;

http://www.clinicaltrials.gov/; http://isrctn.org/; and

http://www.umin.ac.jp/ctr.

This is applicable to clinical trials that have begun enrollment of

subjects in or after June 2018. Clinical trials that have commenced

enrollment of subjects prior to June 2018 would be considered for

publication in Journal of Acute Disease

only if they have been registered retrospectively with clinical trial

registry that allows unhindered online access to public without charging

any fees.

Authorship Criteria

Authorship credit should be based only on substantial contributions to each of the three components mentioned below:

1.      Concept and design of study or acquisition of data or analysis and interpretation of data;

2.      Drafting the article or revising it critically for important intellectual content; and

3.      Final approval of the version to be published.

Participation

solely in the acquisition of funding or the collection of data does not

justify authorship. General supervision of the research group is not

sufficient for authorship. Each contributor should have participated

sufficiently in the work to take public responsibility for appropriate

portions of the content of the manuscript. The order of naming the

contributors should be based on the relative contribution of the

contributor towards the study and writing the manuscript. Once submitted

the order cannot be changed without written consent of all the

contributors. The journal prescribes a maximum number of authors for

manuscripts depending upon the type of manuscript, its scope and number

of institutions involved (vide infra). The authors should provide a

justification, if the number of authors exceeds these limits.

......

更多详见：

https://journals.lww.com/JOAD/Pages/informationforauthors.aspx